SCPH: scPharmaceuticals Inc Company Profile & Statistics

About

scPharmaceuticals, Inc., is a biopharmaceutical company. It engaged in developing pharmaceutical products for subcutaneous delivery. The Company's pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. scPharmaceuticals, Inc., is based in BURLINGTON, United States.

Info & Links

CEO

John H. Tucker

Headquarters

25 BURLINGTON MALL ROAD, SUITE 203
BURLINGTON, MA 01803, UNITED STATES

Auditor

RSM US LLP

Share holders

Employees

136

scPharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

165.13M

Enterprise Value

124.75M

Enterprise Value/EBITDA(ttm)

-1.96

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.27

Price to Book(mrq)

5.20

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

70.02%

Operating Margin(ttm)

-205.76%

Profit Margin(ttm)

-255.03%

Return on Equity(ttm)

-244.93%

Return on Invested Capital(ttm)

-117.85%

Return on Assets(ttm)

-68.56%

Income Statement

Revenue(ttm)

30.28M

Revenue Per Share(ttm)

0.61

Gross Profit(ttm)

21.11M

EBITDA(ttm)³

-63.67M

Net Income Available to Common(ttm)

-80.11M

Diluted EPS(ttm)

-1.90

Share Statistics

Beta (5Y Monthly)

0.14

52-Week Change

-38.20%

S&P 500 52-Week Change

26.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

50.04M

Dividend Yield

0.00%

Float⁴

47.28M

% Held by Insiders

5.52%

% Held by Institutions

89.52%

Balance Sheet

Total Cash(mrq)

91.48M

Total Cash Per Share(mrq)

1.83

Total Debt(mrq)

51.10M

Total Debt/Equity(mrq)

166.40%

Current Ratio(mrq)

8.08%

Quick Ratio(mrq)

6.89%

Book Value Per Share(mrq)

0.61

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.19

Free Cash Flow(ytd)

-55.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SCPH

scPharmaceuticals Inc

scPharmaceuticals Inc Profile